Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Safety and Efficacy of Perrigo's Azelastine/Fluticasone Nasal Spray in Seasonal Allergic Rhinitis
NCT02230696Phase 3Completed
- Sponsor
- Padagis
- Start
- Aug 2014
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of azelastine, fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Padagis. Started Aug 2014; status: completed.
02
Drugs
azelastinefluticasone propionate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT02230696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230696.